Engineered yeast that make cancer drugs could spare a rare flower
TL;DR - Engineered baker’s yeast can produce a precursor to a cancer drug normally sourced from an endangered plant and related species. The approach could reduce pressure on rare botanical resources.
- The work uses modified yeast as a biological production platform.
- It targets a precursor rather than the finished cancer drug.
- The provided excerpt does not specify the precursor, yield, or engineering methods.